Press Releases
AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference
December 14, 2020
MASON, Ohio --(BUSINESS WIRE)--Dec. 14, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 39 th Annual J.P....
AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
November 19, 2020
MASON, Ohio --(BUSINESS WIRE)--Nov. 19, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will participate in the upcoming Piper Sandler 32 nd Annual Virtual...
AtriCure Reports Third Quarter 2020 Financial Results
November 05, 2020
Worldwide revenue of $54.8 million – a decrease of 3.3% year over year U.S. revenue of $44.7 million – a decrease of 3.1% year over year International revenue of $10.1 million – a decrease of 4.1% year over year MASON, Ohio --(BUSINESS WIRE)--Nov. 5, 2020-- AtriCure, Inc....
AtriCure to Participate in Upcoming Investor Conferences
October 26, 2020
MASON, Ohio --(BUSINESS WIRE)--Oct. 26, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in two upcoming investor conferences....